- Home
- TRIB vs SILO Comparison
TRIB vs SILO Comparison
Compare TRIB & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- SILO
- Stock Information
- Founded
- TRIB 1992
- SILO 2010
- Country
- TRIB Ireland
- SILO United States
- Employees
- TRIB N/A
- SILO N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SILO Apparel
- Sector
- TRIB Health Care
- SILO Consumer Discretionary
- Exchange
- TRIB Nasdaq
- SILO Nasdaq
- Market Cap
- TRIB 5.4M
- SILO 5.9M
- IPO Year
- TRIB N/A
- SILO N/A
- Fundamental
- Price
- TRIB $1.11
- SILO $0.59
- Analyst Decision
- TRIB
- SILO
- Analyst Count
- TRIB 0
- SILO 0
- Target Price
- TRIB N/A
- SILO N/A
- AVG Volume (30 Days)
- TRIB 13.5M
- SILO 295.0K
- Earning Date
- TRIB 11-14-2025
- SILO 08-13-2025
- Dividend Yield
- TRIB N/A
- SILO N/A
- EPS Growth
- TRIB N/A
- SILO N/A
- EPS
- TRIB N/A
- SILO N/A
- Revenue
- TRIB $61,555,000.00
- SILO $72,102.00
- Revenue This Year
- TRIB $13.51
- SILO $1.86
- Revenue Next Year
- TRIB $13.14
- SILO N/A
- P/E Ratio
- TRIB N/A
- SILO N/A
- Revenue Growth
- TRIB 8.31
- SILO N/A
- 52 Week Low
- TRIB $0.48
- SILO $0.41
- 52 Week High
- TRIB $3.44
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- TRIB 45.04
- SILO 42.06
- Support Level
- TRIB $1.42
- SILO $0.59
- Resistance Level
- TRIB $1.58
- SILO $0.65
- Average True Range (ATR)
- TRIB 0.15
- SILO 0.04
- MACD
- TRIB -0.07
- SILO -0.01
- Stochastic Oscillator
- TRIB 2.80
- SILO 12.63
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.